# A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma

> **NCT03424291** · PHASE2 · UNKNOWN · sponsor: **Henan Cancer Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** Apatinib plus chemoradiation

## Key facts

- **NCT ID:** NCT03424291
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-05
- **Primary completion:** 2018-07
- **Final completion:** 2019-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2018-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03424291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03424291, "A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03424291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*